Skip to content
‹ Back to IndustriesSciences

Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Novaspace forecasts more than 6,500 Earth observation satellites launching by 2035. It also projects $155.9 billion in manufacturing revenue, based on a SpaceNews-posted release dated Aug. 21, 2026. As defense-led demand shifts toward revisit rate and persistence, payload integration and fleet interoperability become the hard parts.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · NovaspaceSpacenewsEarth ObservationEo Satellites
Share
Listen to the audio brief

Key facts, context, and what it means.

AUDIO
0:00—
Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Key takeaways

01

$155.9 billion is tied specifically to satellite manufacturing, not launch or ground, which should reshape how teams size supplier commitments and make-buy decisions.

02

Novaspace’s “skyscraper model” framing implies procurement power is shifting to payload integration, test capacity, and software-defined operations, even as the bus becomes more standardized.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

More than 6,500 Earth observation satellites are expected to launch by 2035, and Novaspace puts the associated manufacturing revenue at $155.9 billion. That forecast, published Aug. 21, 2026 in a SpaceNews-posted Novaspace release, is a reminder that the space industrial base is no longer being asked to build a handful of exquisite spacecraft. It’s being asked to build fleets, with defense-grade tasking expectations.

For operators inside satellite primes, payload suppliers, and program offices, the same Novaspace release highlights a shift that matters beyond the headline totals. According to SpaceNews, Novaspace says performance is being measured more by revisit rates, persistence and wide-area coverage than by resolution alone. That change is pushing operators toward bigger constellations and a wider mix of sensor designs.

The number that will show up in supplier negotiations: $155.9 billion in manufacturing

Novaspace is explicit about what its $155.9 billion represents: manufacturing revenues tied to Earth observation satellites through 2035, driven by governments expanding sovereign intelligence, surveillance, and reconnaissance capabilities, according to SpaceNews. That scope matters for procurement teams who keep seeing “space market” numbers that quietly bundle launch, ground infrastructure, and downstream services into a single pie chart.

Treat this forecast as a budgeting reality check. If manufacturing is the cited revenue pool, then capacity planning conversations should land on long-lead components, test throughput, and qualified suppliers, not just launch cadence or downlink capacity.

Multi-sensor constellations raise integration work even as buses standardize

According to SpaceNews, Novaspace says the change is speeding up use of multi-sensor constellations that pair synthetic aperture radar (SAR), optical and radio frequency (RF) payloads. Novaspace says that bringing together complementary intelligence sources can deliver Earth observation that is both more resilient and more comprehensive, while still satisfying increasingly demanding defense requirements.

The SpaceNews-posted release also outlines a “skyscraper model.” According to Novaspace, as satellite buses become more standardized, value shifts to integrating advanced payloads along with multiple intelligence layers.

Interoperability and fleet management become part of the spec

As constellations scale, Novaspace says demand is rising for interoperability, federation, and fleet management, according to SpaceNews. Those words can read like strategy, but they turn into line items fast: cross-mission tasking, common data standards, shared command-and-control workflows, and operational tooling that can handle mixed vendors and mixed sensors without bespoke integration every time.

As EO constellations increase in size and complexity, Novaspace says the need is rising for interoperability, federation and fleet management, according to SpaceNews. Novaspace says those developments are bringing commercial and defense markets closer together and making sovereign Earth observation capabilities a central engine of market growth through 2035.

A separate Novaspace forecast points to rate production stress

The EO forecast lands inside a broader manufacturing ramp. CompositesWorld, in an Oct. 10, 2025 item edited by Ginger Gardiner, reported Novaspace’s projection that 43,000 satellites would be launched in 2025, 2034, averaging 12 satellites per day, and tied the growth to mega-constellations, defense demand, and rapid innovation.

Even though that is a different Novaspace report and timeframe, it provides a production-rate reference point for suppliers watching EO specifically. CompositesWorld reports that Novaspace’s annual forecast calls for record growth in satellites to be built and launched, averaging 12 satellites per day, and notes that this growth will drive increased use of composites in launch vehicle and satellite structures. If the industry is organized around “satellites per day,” then materials and structures suppliers have to plan for qualification pathways that look more like aerospace series production than one-off space builds.

Questions to bring into 2027 EO constellation sourcing and integration

  • For payload and subsystem buyers: how will vendors commit to interface stability (mechanical, electrical, software) across SAR, optical, and RF payload mixes over multiple lots, given Novaspace’s multi-sensor direction (SpaceNews)?
  • For manufacturing ops leaders: what is the limiting resource in the schedule, payload availability, integration labor, or environmental test throughput, if bus standardization rises as Novaspace’s “skyscraper model” suggests (SpaceNews)?
  • For program and ground-segment teams: what concrete interoperability requirements belong in the RFP now (tasking APIs, data formats, federation rules), since Novaspace flags interoperability and federation demand as constellations scale (SpaceNews)?
  • For materials and structures suppliers: what production-rate assumptions are realistic for composite parts and panel fabrication if industry forecasts are being expressed in “satellites per day,” as CompositesWorld summarized from Novaspace’s 2025-2034 outlook?

Featured companies

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

IndexBox sees replacements driving a third of quantum cascade laser shipments by 2030

IndexBox sees replacements driving a third of quantum cascade laser shipments by 2030

The quantum cascade laser market is projected to grow 8% to 12% a year through 2035, driven by mid-infrared spectroscopy in process control, environmental monitoring and pharmaceutical quality checks. In these uses, the lasers offer high spectral brightness and run at room temperature in compact form factors. The installed base of analytical instruments is also growing.

  • 01Roughly one in three quantum cascade lasers shipped in 2030 is projected to replace equipment already in service, so maintenance calendars will set a growing share of demand.
  • 02For a plant or QA lab running QCL-based analyzers, the useful question is which laser maker sits inside each instrument and whether a second source exists.
  • 03Analyzers bought on a three-to-five-year cycle in 2026 come due between 2029 and 2031. Those years will show whether the forecast replacement wave turns up in real orders.

Oct 26, 2026

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu cites digitalization, personalization and large-volume delivery as trends reshaping drug delivery devices, arguing structured data can enable reuse and cut duplicated design-file work for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of IV and SC agents.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan prefilled syringe plant in Shenzhen won the Innovation (Novel Technology) category at ISPE's 2026 Facility of the Year Awards. In the transcript ISPE posted with its podcast, CaiXue Wei describes vertical design, AGV-assisted transfer, AI inspection and 5G-MEC as one integrated system built around a 330 million-syringe annual capacity; Hepalink's own release adds a 24-meter warehouse, sub-10 millisecond 5G and 24,000-unit-an-hour inspection.

  • 01Hepalink's 24-meter automated warehouse raised space utilization 52 percent over a traditional layout on a land-scarce Shenzhen site supporting 330 million syringes a year.
  • 02AGVs pass material through vaporized hydrogen peroxide chambers straight into Grade A isolators, and Hepalink credits the zero-touch flow for a 100 percent first media fill.

Oct 22, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512